Remove tag venture-capital
article thumbnail

Actualising the power of antibody-drug conjugates as cancer therapeutics

European Pharmaceutical Review

tag ® , inspired by the unique features of microtubule biology and perfectly suited for DAR 2 and DAR 4 ADCs. This is based on ethynylphosphonamidates that prevent premature cleavage of the linker payload during circulation and increasing hydrophilicity of the ADC while keeping the distance between antibody and payload to a minimum.

article thumbnail

Finout Rolls Out FinOps Dashboards to Transform Cloud Costs into Business Value

Pharmaceutical Technology

Using sophisticated assignment rules and virtual tagging, each line item inside the unified bill can be assigned to its business role, feature, team, and product. million from Team8 Capital, Pitango First, R Squared Ventures, Jibe Ventures, and Ariel Maislos. In June 2022, the startup raised $18.5